Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.22.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues:    
Total revenues $ 192 $ 682
Operating expenses:    
Cost of goods sold 0 110
Research and development 1,409 1,877
General and administrative 1,322 1,327
Total operating expenses 2,731 3,314
Loss from operations (2,539) (2,632)
Other expense:    
Interest expense, net 0 (1)
Other expense, net (1) (8)
Other expense, net (1) (9)
Net loss $ (2,540) $ (2,641)
Basic net loss per common share $ (0.24) $ (0.28)
Diluted net loss per common share $ (0.24) $ (0.28)
Weighted average shares used in computing basic net loss per common share 10,729 9,289
Weighted average shares used in computing diluted net loss per common share 10,729 9,289
License revenue    
Revenues:    
Total revenues $ 3 $ 2
Product revenue    
Revenues:    
Total revenues 0 111
Grant revenue    
Revenues:    
Total revenues $ 189 $ 569